By MobiHealthNews | Oct 16, 2017
While the third quarter’s digital health funding may not have met the staggering scale of its predecessor, MobiHealthNews still tracked 53 deals during July, August, and September totaling $578.55 million. Below, we’ve listed all of the companies that raised equity from investors along with links to MobiHealthNews’ coverage at the time. Deals are ranked in order from largest to smallest. If applicable, investments have been converted to USD based on the exchange rate at the original article’s time of publication.
AbleTo — $36.6 million. Behavioral health technology company AbleTo secured $36.6 million in financing last week, led by Bain Capital Ventures. All of its existing investors — 406 Ventures, Sandbox Industries, HLM Venture Partners, and Horizon Healthcare Services — participated in the Series B round as well. Strategic investor Aetna also chipped in.
Talkspace — $31 million. Online therapy company Talkspace is now flush with $31 million in new financing. Qumra Capital, an Israel-based growth stage fund, led the Series C round and was joined by existing investors Norwest Venture Partners, Spark Capital, SoftBank, Compound Ventures, and FirstTime. Erez Shachar, a managing partner at Qumra Capital, will join the Talkspace board of directors.
Push Doctor — $26.1 million. UK-based Push Doctor, a provider of app-based virtual visits, has raised $26.1 million in Series B financing in a round led by Accelerated Digital Ventures and Draper Esprit. Oxford Capital, Partech Ventures, and Seventure Partners also contributed, bringing Push Doctors’ total funding to date to more than $37.5 million. The company last raised money in January 2016.
PatientSafe — $25 million. PatientSafe Solutions, the San Diego, California-based developer of the PatientTouch workflow-optimizing platform, announced that it has secured $25 million in its latest round of funding. Private investment firm HighBar Partners was the primary contributor, with additional capital coming from the Merck Global Health Innovation Fund, Camden Partners, Psilos Group, and TPG.
SPR Therapeutics — $25 million. SPR Therapeutics, the Cleveland, Ohio-based developer of a wearable pain management device, announced yesterday the completion of $25 million in Series C financing. The company’s new funding — primarily secured from Frontcourt Ventures and an unnamed family office — will support commercialization of the Sprint Peripheral Nerve Stimulation System, and investigate its applicability across indications.
Truveris — $25 million. Truveris, a healthcare technology company focused on cloud-based data analytics solutions for the $450 billion prescription benefits industry, announced that it has secured $25 million in a new round of funding to accelerate its growth strategies. The Series D round was led by McKesson Ventures, and included Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and New Atlantic Ventures.
Wellframe — $25 million. Boston-based Wellframe, makers of mobile patient engagement and care management software, has raised $15 million in Series B funding led by F-Prime Capital. Existing investor DFJ also contributed, and the new capital brings the company’s total funding to date to $25 million.
Call9 — $24 million. Brooklyn-based Call9 has raised $24 million in a new round of funding. Redmile led the round, with additional investments from Index Ventures, Refactor, YCombinator, Western Technology Investments, and other undisclosed investors. This is the second round of funding for the company, which raised $10 million in January 2016. The new funding will be used to scale Call9’s operations.
Ieso Digital Health — $24 million. Ieso Digital Health, a Cambridge, UK-based digital behavioral health company, has raised $24 million in a new round of funding led by European VC firms Draper Esprit and Touchstone Innovations.
Stride Health — $23.5 million. Stride Health, a company that provides benefits for independent workers, has raised $23.5 million in a Series B financing round led by F-Prime Capital Partners, with participation from existing investors Venrock and New Enterprise Associates — as well as new investors, including Portag3 Ventures. The additional capital will fuel the expansion of Stride Health’s benefits offerings, with an eye toward providing independent workers with additional support.
98point6 — $19.5 million. Chat-based telemedicine company 98point6 has raised $19.5 million in third-round funding. The round comes from undisclosed private investors and brings the company’s total funding to $35 million, according to the company.
Lumity — $19 million. Lumity, a San Mateo-based employee benefits software company, has raised $19 million in a new round led by DFJ. Social+Capital Partnership and True Ventures, both previous investors, also contributed to the round, which brings Lumity’s total funding to $33 million. The company raised $14 million in 2015.
Solera Health — $18.3 million. Solera Health, the Phoenix-based company that has created a marketplace for digital and in-person diabetes prevention programs, has raised $18.3 million in a round led by Adams Street Partners, with additional participation from Blue Cross Blue Shield Venture Partners, Sandbox Industries, and SJF Ventures. The round, Solera’s largest to date, brings its total funding to $30.3 million.
Artemis Health — $16 million. Artemis Health, which offers a benefit optimization data platform for employers, just received $16 million in Series B funding, led by an investment from F-Prime Capital. There was also participation in the round from Maverick Ventures and Kickstart Seed Fund, both previous investors. This is the second major round of funding Artemis Health has raised in 12 months, totaling $26 million to date. The funds are earmarked for a rapid expansion through investments in thought leadership, product research and development, and key executive hires.
BrainScope — $16 million. Bethesda, Maryland-based BrainScope, which makes mobile, non-invasive devices that help medical professionals assess traumatic brain injury, has raised $16 milion. New investor DBL Partners contributed along with existing investors Revolution LLC, ZG Ventures, and Maryland Venture Fund.
Viome — $15 million. Viome, which has developed technology aimed at balancing microorganisms in the gut, has landed $15 million in capital. The funds will go towards the launch of the company’s at-home health kit, which targets the microbiome.
Antidote Technologies — $11 million. Boston-based Antidote Technologies has entered into an agreement for an $11 million funding round led by Merck Global Health Innovation Fund, and joined by existing investors Smedvig Capital and Octopus Ventures. With this, Antidote expects it will soon be able to accelerate the development of capabilities for its trial matching platform – including precision medicine and EHR matching. Regulatory clearances still need to come through, but that’s expected to happen later this year.
CellTrak — $11 million. CellTrak, an early entrant into the mobile health space that focuses on connecting home caregivers, has raised $11 million. Boathouse Capital led the round with participation from existing investor MK Capital. This brings the company’s total funding to $23 million.
Maven — $10.8 million. New York-based Maven, a digital women’s health clinic, has raised $10.8 million in a Series A financing round that brings the company’s total funding to more than $15 million, the company announced. The round was led by Spring Mountain Capital with participation from 14W, DGNL, and Colle Capital.
Circulation — $10.5 million. Circulation is looking to change the way non-emergency patients are delivered to the hospital, and those efforts were bolstered Tuesday by the news that it raised $10.5 million in Series A financing from a group of leaders across the healthcare system. Flare Capital Partners and The Providence Service Corporation co-led the investment and were joined by Boston Children’s Hospital, Echo Health Ventures (a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions), Intermountain Healthcare Innovation Fund (a strategic investment vehicle of Intermountain Healthcare, managed by Healthbox), Humana, NextGen Venture Partners and the world’s leading healthcare diagnostics company.
8fit — $10 million. Berlin-based 8fit has raised $10 million in its first round of funding to support its health and fitness app of the same name. Creandum, a European VC investor, and Eight Roads Ventures, a global firm, co-led the round.
Phil — $10 million. Phil, a San Francisco-based prescription refill and delivery service, has raised $10 million in a round led by Crosslink Capital. Eniac Ventures, Softtech VC, Forerunner Ventures, SV Angel, Silicon Valley Bank, and Transmedia Capital also contributed to the round.
Augmedics — $8.3 million. Yokneam, Israel-based Augmedics, a company building augmented reality glasses for surgeons, has raised $8.3 million in new funding. AO Invest, the investment arm of surgeon-led nonprofit the AO Foundation, co-led the round with the Israeli Innovation Authority. Other contributions came from Terra Venture Partners and additional undisclosed investors.
Bright.MD — $8 million. Portland, Oregon-based Bright.md has scored a fresh injection of cash in an $8 million Series B funding round aimed at improving patient care and lowering healthcare costs for clinicians. B Capital Group led the round with participation from return backer Seven Peaks Ventures.
Hinge Health — $8 million. San Francisco and London-based Hinge Health, which makes a scalable digital health program for treating musculoskeletal (MSK) conditions, has raised $8 million in a new round of funding led by Atomico. All the company’s seed investors, including Eleven Two Capital and The Vertical Group, also participated in the round.
MedAware — $8 million. Raannana, Israel-based MedAware, which leverages machine learning algorithms to find and eliminate dangerous prescription errors, has raised $8 million. BD (Becton, Dickinson and Company), Gefen Capital, OurCrowd, and Yingcheng City Fubon Technology Company all participated in the Series A round. In addition to the $8 million in venture funds, MedAware has picked up $4 million in grants from Israel’s Innovation Authority, the BIRD Foundation, and the European Commission.
PhysIQ — $8 million. As a concept, using artificial intelligence to monitor the health of ambulatory patients got a boost as physIQ, an AI-centered healthcare outfit, closed $8 million in Series B financing, led by 4490 Ventures. Joining 4490 is the Global Health Sciences Fund through Quark Venture Inc. and GF Securities, along with existing investor LionBird and others.
LVL Technologies — $6.75 million. Austin, Texas-based LVL Technologies (formerly known as BSX Athletics) has raised $6.75 million in a self-described Series A round led by the Samsung Catalyst Fund. Maxim Integrated Products also contributed along with other industry investors. This is actually the company’s second Series A round; according to a now-deleted blog post on the company’s website, it already raised a $2.5 million Series A back in 2013 from six undisclosed private investors. That would bring its total funding to $9 million.
Buoy Health — $6.7 million. Buoy Health, makers of a machine learning-powered next generation symptom checker, has raised $6.7 million in a round co-led by F Prime (the venture arm of Fidelity) and an undisclosed strategic investor in the payer space. FundRx and various angel investors also contributed.
Cardinal Analytx — $6.1 million. Cardinal Analytx, a new population health management company founded by Cardinal Partners investor Thomas McKinley based on research from Stanford University, has raised $6.1 million. Cardinal Partners led the round, with participation from the Stanford-StartX Fund and Premera Blue Cross, which also participated in a large pilot study that has provided some initial validation for the company.
Aifloo — $6 million. Swedish outfit Aifloo, which produces a smart wristband powered by artificial intelligence, has raised $6 million in new funding, according to TechCrunch. EQT Ventures led the Series A funding round.
GNS Healthcare — $6 million. Precision medicine company GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures, with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company’s REFS causal machine learning and simulation platform — as well as solutions across drug discovery and development, value-based drug solutions, and care management.
PeakMed — $5.5 million. PeakMed, a company that seeks to provide affordable family practice medicine through a monthly membership model, has raised new funds to the tune of $5.5 million, led by ASI Capital. The financial backing will support PeakMed’s expansion, which includes new LifeCenters, telemedicine technology, vehicles for house calls, and additional staff.
MyDoc — $5.2 million. Singapore-based startup MyDoc has collected $5.2 million in Series A funding. The investment was primarily received from Aliso Viejo, California-based digital and IT services provider UST Global, with additional funds coming from venture capital firm Wavemaker Partners and others. The money will continue financing development of MyDoc@Work, the startup’s digital healthcare platform designed for corporate employees.
Iris Plans — $5.1 million. Austin, Texas-based Iris Plans, which offers remote video visits to facilitate advanced care and end-of-life planning, has raised $5.1 million. Activate Venture Partners and LiveOak Venture Partners led the round, with additional participation from Better Ventures and other undisclosed investors.
Flo — $5 million. AI-driven women’s health platform Flo has raised $5 million in a Series A funding round, led by Flint Capital, which, along with Haxus Fund, tossed in $1 million in seed round funding in December 2016. Other investors in the Series A round include Natalia Vodianova, a supermodel and social activist who also joined the company’s board of directors, as well as a handful of angel investors.
PriorAuthNow — $3.6 million. PriorAuthNow, a platform for connecting the healthcare landscape using prior authorization automation, has closed a $3.6 million investment funding round led by NCT Ventures, with participation from Detroit Venture Partners. The company will use the extra money to advance its mission, which is essentially to disrupt the prior authorization industry, valued at about $31 billion.
Analyte Health — $3 million. Analyte Health, a Chicago-based lab networking platform active in telehealth, has raised just over $3 million, according to a recent SEC filing. The document lists three unnamed investors.
Fruit Street Health — $3 million. Fruit Street Health, a digital health and telemedicine company currently focused on delivering a digital diabetes prevention program, has raised $3 million in new funding from physician investors. Dr. Jeremy Tucker, a senior emergency medicine physician on the board of directors of Fruit Street, led the round, which brings the company’s total funding to $8.4 million.
HealthJoy — $3 million. Chicago-based HealthJoy, an artificial intelligence-driven platform for employee benefits engagement and cost containment, has netted $3 million in a Series A round of financing. Chicago Ventures led the round, with participation from Social Capital, Sidekick Fund and HealthJoy’s seed-round lead, Go-Health. Also included in the round were Angel investments from leaders in technology and health innovation including Andrew Sieja, CEO of KCura; Brad Hoover, CEO of Grammarly; Ben Evans, CEO of OurHealth; Eduardo Vivas, founder of Bright.com; and Jason Theofilis, CEO of MUNDOMedia.
iBeat — $3 million. Wearable technology company iBeat has gotten a fresh injection of cash, scoring another $3 million in funding to bring its total seed stage funding to $4.5 million. In addition to a health records platform, iBeat is now building a new wearable device that monitors and analyzes users’ heart activity.
Protenus — $3 million. Protenus, a patient protection solution aimed at preventing health data breaches, has undergone a $3 million extension of its Series A funding round, led by Kaiser Permanente Ventures with participation from F-Prime Capital Partners and existing investor LionBird Venture Partners. The new investment will be used to bolster its product, expand its offerings, and accelerate sales growth.
Signature Medical — $2.5 million. Bose may be known mainly for high-end speakers and audio systems, but the company has recently become an investor in the healthcare space, contributing to $2.5 million in a Series A funding round for Signature Medical Inc., an Allied Minds portfolio company. Allied Minds is also an investor, as is Riot Ventures, an early-stage investment group focused on emerging technologies.
Tia — $2.5 million. Women’s health app developer Tia announced that it has received $2.5 million in seed financing to continue developing its service and expanding its brand. The funding was acquired from early stage investment groups Combine, Homebrew, and Compound.
BloomAPI — $2.4 million. Seattle, Washington-based BloomAPI has raised $2.4 million for its medical records processing software. Y Combinator, Slow Ventures, Founder’s Co-Op, Section 32, Liquid 2 Ventures, and Parker Conrad all contributed to the round.
DreamJay — $2.3 million. DreamJay, a San Francisco- and Warsaw, Poland-based sleep app developer, announced that it has raised $2.3 million in Series A funding. Investors include the Joint Polish Investment Fund (JPIF), Poland’s largest life science venture capital fund, and Nordic Makers, a Swedish fund. The newly acquired capital will be used to continue development of Nightly, DreamJay’s unreleased app, and finance the additional clinical research required to submit the app for premarket FDA review and European CE mark certification.
Cara — $2 million. Cara, a Berlin-based startup building a medical app for digestive health, has raised a $2 million seed round. Atlantic Labs led the round, and additional investments came from angel investors. The company does business as Cara, the name of its app, but is officially known as HiDoc.
easyScripts — $2 million. Chicago-based eazyScripts, a provider of e-prescribing software for telemedicine, has completed $2 million in Series A financing through private equity firm Bluff Point Associates. The company’s e-prescribing solution was built to address the specific needs of telemedicine providers, aiming for a user experience that’s fast and efficient.
Mendel.ai — $2 million. San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital, and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use.
Groove Health — $1.6 million. Chicago-based digital health company Groove Health has raised $1.6 million for its predictive analytics platform, which focuses on personalized patient engagement to help health insurance companies, hospital systems, and self-insured employers improve their medication adherence. The investors in the round were not disclosed.
Satchel Health —$1.5 million. Nashville, Tennessee-based Satchel Health has picked up another $1.5 million in funding, less than a year after its million-dollar angel round. Existing investor NueCura Partners contributed along with an unnamed group of local investors. This brings the company’s total funding to about $2.5 million.
Locum’s Nest — $1.4 million. Locum’s Nest, a UK technology startup aiming to disrupt the way NHS hospitals staff temporary doctor vacancies, has raised $1.4 million in a round led by UK investment manager Albion Capital and Oman-based innovation firm IDO Investments.
Welltory — $1 million. Welltory, a New York-based startup working on a stress and energy management app, has closed its second investment round, nabbing $1 million from business angels to launch the next version of its software — a data-driven tool that aims to help people reduce their stress and boost productivity.